Diamond Biotechnology Co (6815.TWO) Stock Price
Diamond Biotechnology Co Price
Over the last 8 years Diamond Biotechnology Co grew revenue by 12.7% annually, reaching 501.49 M TWD. Earnings per share have grown at 2.4% per year over the last 7 years. For Diamond Biotechnology Co, the net margin of -14.0% is down versus 10.6% a few years ago. At today's price the dividend yield works out to roughly 0.87%. The dividend has grown at 17.6% per year over the past 3 years.
Diamond Biotechnology Co stock price
Diamond Biotechnology Co business model & stock analysis
Frequently asked questions about Diamond Biotechnology Co
Converted at the current exchange rate, the Diamond Biotechnology Co share trades at 0.63 EUR (22.60 TWD).
The revenue cannot currently be calculated for Diamond Biotechnology Co.
The profit cannot currently be calculated for Diamond Biotechnology Co.
The P/E ratio cannot be calculated for Diamond Biotechnology Co at the moment.
The P/S cannot be calculated for Diamond Biotechnology Co currently.
The Eulerpool Quality Score for Diamond Biotechnology Co is 1/10.
The ISIN of Diamond Biotechnology Co is TW0006815004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Diamond Biotechnology Co is 6815.TWO. The ticker symbol is used to trade Diamond Biotechnology Co shares on the stock exchange.
Diamond Biotechnology Co stock
Diamond Biotechnology Co Peer Group
Diamond Biotechnology Co FIGI
All fundamentals and in-depth analysis of Diamond Biotechnology Co
Our stock analysis for Diamond Biotechnology Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Diamond Biotechnology Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.